Express Pharma
Home  »  Latest Updates  »  US FDA approves AstraZeneca’s diabetes drug for treating heart failure risk

US FDA approves AstraZeneca’s diabetes drug for treating heart failure risk

The approval by the US Food and Drug Administration is based on results from the DECLARE-TIMI 58 clinical trial

0 35

AstraZeneca said US regulators approved its diabetes drug Farxiga to be used as a treatment to reduce the chances of hospitalisation for heart failure in adults with type-2 diabetes and other cardiovascular risks.

The approval by the US Food and Drug Administration is based on results from the DECLARE-TIMI 58 clinical trial, the British drugmaker said and follows a similar approval by the European authorities in August.

Diabetes is associated with a high risk of heart failure.

Leave A Reply

Your email address will not be published.